These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31145924)

  • 1. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
    Huang Y; Su BN; Marshall J; Miller SA
    J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling degradants of paclitaxel using liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry substructural techniques.
    Volk KJ; Hill SE; Kerns EH; Lee MS
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):99-115. PubMed ID: 9300914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation studies of elagolix sodium with the implementation of high resolution LC-UV-PDA-MS
    Zhong X; Lv Q; Yong Q; Hu W; Li D; Ji S; Zhan L; Chen W; Li M; Lin J; Sun C
    J Pharm Biomed Anal; 2023 Feb; 224():115198. PubMed ID: 36495708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation.
    Reid DL; Calvitt CJ; Zell MT; Miller KG; Kingsmill CA
    Pharm Res; 2004 Sep; 21(9):1708-17. PubMed ID: 15497700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
    Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
    Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative degradation pathways of beclabuvir hydrochloride mediated by hydrogen peroxide and UV/Vis light.
    Ye Q; Huang Y; Grier S; Miller SA
    J Pharm Biomed Anal; 2019 Aug; 172():388-394. PubMed ID: 31100536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of Unprecedented Degradants of Domperidone by Ultra-Performance Convergence Chromatography and Their Structure Elucidation.
    Mutha VVSRNAK; Chandra C; Vijayabhaskar B; Achanta PS; Narkedimilli J; Kaliyaperumal M; Korupolu RB; Gajbhiye SB; Rumalla CS
    J Chromatogr Sci; 2019 Oct; 57(9):806-814. PubMed ID: 31504287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced degradation of fentanyl: identification and analysis of impurities and degradants.
    Garg A; Solas DW; Takahashi LH; Cassella JV
    J Pharm Biomed Anal; 2010 Nov; 53(3):325-34. PubMed ID: 20462721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
    Singh DK; Sahu A; Handa T; Narayanam M; Singh S
    J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance.
    Baertschi SW; Maxwell-Backer L; Clemens M; Smitka TA; Draper JR; Taylor KW; Kaerner A; Jansen PJ
    J Pharm Sci; 2019 Sep; 108(9):2842-2857. PubMed ID: 30981754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
    Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
    J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural elucidation of two novel degradants of lurasidone and their formation mechanisms under free radical-mediated oxidative and photolytic conditions via liquid chromatography-photodiode array/ultraviolet-tandem mass spectrometry and one-dimensional/two-dimensional nuclear magnetic resonance spectroscopy.
    Wang KC; Guo Q; Kuang Z; Jin J; Li D; Chen W; Zhu W; Li M
    J Mass Spectrom; 2022 Jul; 57(7):e4871. PubMed ID: 35739062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
    Rao RN; Ramakrishna K; Sravan B; Santhakumar K
    J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
    Mahadik M; Bhusari V; Kulkarni M; Dhaneshwar S
    J Pharm Biomed Anal; 2009 Dec; 50(5):787-93. PubMed ID: 19615841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, isolation and characterization of dolutegravir forced degradation products and their cytotoxicity potential.
    Saida SJ; Manikandan A; Kaliyaperumal M; Rumalla CS; Khan AA; Jayaraman VB; Yanaka R; Venkat Rao S
    J Pharm Biomed Anal; 2019 Sep; 174():588-594. PubMed ID: 31261040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.